Evidence map›Paper›PMID 32283768›Full record

ArticleViruses2020

Bacteriophage ZCSE2 is a Potent Antimicrobial Against

Ahmed Mohamed, Omar Taha, Hesham M El-Sherif, Phillippa L Connerton, Steven P T Hooton, Nabil D Bassim, Ian F Connerton, Ayman El-Shibiny

Open access · goldAbstract read
In one paragraph

Article in Viruses, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 38 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. In Vitro Insights into the Anti-Biofilm Potential ofAntibiotics (Basel, Switzerland) · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Efficacy ofViruses · 2021
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Characteristics of a Series of Three Bacteriophages InfectingInternational journal of molecular sciences · 2020
    Article
  13. Phage S144, A New Polyvalent Phage InfectingInternational journal of molecular sciences · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 3 countries.

Ahmed MohamedCenter for Microbiology and Phage Therapy, Biomedical Sciences, Zewail City of Science and Technology, Giza 12578, Egypt.
Omar TahaCenter for Microbiology and Phage Therapy, Biomedical Sciences, Zewail City of Science and Technology, Giza 12578, Egypt.
Hesham M El-SherifMechanical Design and Production Engineering Department, Faculty of Engineering, Cairo University, Giza 12613, Egypt.ORCID 0000-0001-6875-0762
Phillippa L ConnertonDivision of Microbiology, Brewing and Biotechnology, School of Biosciences, University of Nottingham, Loughborough LE12 5RD, UK.
Steven P T HootonDivision of Microbiology, Brewing and Biotechnology, School of Biosciences, University of Nottingham, Loughborough LE12 5RD, UK.
Nabil D BassimMaterials Science and Engineering Department, McMaster University, 1280 Main Street West, Hamilton, ON L8S 4L8, Canada.
Ian F ConnertonDivision of Microbiology, Brewing and Biotechnology, School of Biosciences, University of Nottingham, Loughborough LE12 5RD, UK.ORCID 0000-0001-8652-8938
Ayman El-ShibinyCenter for Microbiology and Phage Therapy, Biomedical Sciences, Zewail City of Science and Technology, Giza 12578, Egypt.
University of Nottingham · GBZewail City of Science and Technology · EGArish University · EGCairo University · EGMcMaster University · CA

Funding

Biotechnology and Biological Sciences Research Council BB/GCRF-IAA/15
6 · The paper itself

Abstract

Developing novel antimicrobials capable of controlling multidrug-resistant bacterial pathogens is essential to restrict the use of antibiotics. Bacteriophages (phages) constitute a major resource that can be harnessed as an alternative to traditional antimicrobial therapies. Phage ZCSE2 was isolated among several others from raw sewage but was distinguished by broad-spectrum activity against

Indexed as

BacteriolysisGenome, ViralGenomicsMicroscopy, Atomic ForcePhage TherapySalmonella entericaSalmonella InfectionsSalmonella PhagesWhole Genome Sequencingatomic force microscopybacteriophagephage biocontrolSalmonella

Identifiers

PMID32283768
PMCPMC7232530
OpenAlexW3016198462

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.